TRIANNI Announces BIO Asia International Conference Sponsorship

San Francisco, CA, USA., February 23, 2016 – TRIANNI, Inc. (“Trianni”), a biotechnology company with proprietary antibody discovery technology, announced […]

Continue reading

Achaogen and TRIANNI Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

San Francisco, CA, and South San Francisco, CA – February 8, 2016 – TRIANNI, Inc. (“TRIANNI”) and Achaogen, Inc. (NASDAQ:AKAO), […]

Continue reading